Sterile Injectable Manufacturing: SOP for Sanitization of Isolators in Sterile Manufacturing – V 2.0
Standard Operating Procedure for Sanitization of Isolators in Sterile Manufacturing
| Department |
Sterile Injectable Manufacturing |
| SOP No. |
SOP/SIM/155/2025 |
| Supersedes |
SOP/SIM/155/2022 |
| Page No. |
Page 1 of 14 |
| Issue Date |
24/06/2025 |
| Effective Date |
26/06/2025 |
| Review Date |
24/06/2026 |
1. Purpose
To define the procedure for sanitization of isolators used in sterile injectable manufacturing. This SOP ensures consistent and effective decontamination practices, preventing microbial contamination and maintaining aseptic processing environments in compliance with cGMP and regulatory standards.
2. Scope
This SOP applies
to all isolators used in sterile areas of the facility for aseptic manufacturing operations, including those used in filling lines, compounding operations, and sampling procedures.
3. Responsibilities
- Production Operator: Carries out the sanitization as per the SOP.
- Engineering: Ensures proper functioning of isolator systems and environmental controls.
- QA Officer: Monitors compliance with procedure and approves sanitization records.
4. Accountability
The Head of Production and Head of QA are accountable for the proper execution and verification of isolator sanitization activities.
5. Procedure
5.1 Preparation for Sanitization
- Ensure isolator is shut down and power to glove ports and internal fans is turned off.
- Verify isolator chamber is empty and free from manufacturing components or product remnants.
- Check the availability of sanitizing agents, cleaning tools, and personal protective equipment (PPE).
- Wear approved sterile PPE before entering the Grade B/C area where the isolator is located.
5.2 Cleaning Before Sanitization
- Using a sterile lint-free cloth soaked in Water for Injection (WFI), clean all internal isolator surfaces including walls, glass, and stainless steel surfaces.
- Remove residues, visible particles, and any dried product using a non-abrasive motion.
- Change the cloth when visibly dirty or after each major surface to avoid cross-contamination.
- Allow to dry or wipe with a dry sterile cloth if required.
5.3 Sanitization with Disinfectants
- Use an approved sporicidal disinfectant (e.g., Hydrogen Peroxide, Peracetic Acid) as per the disinfectant rotation policy.
- Spray or fog the disinfectant using validated equipment designed for isolators or vaporized hydrogen peroxide (VHP) systems.
- Ensure full coverage including glove ports, viewing window interiors, air intake filters, and floor plates.
- Maintain the required contact time (e.g., 30 minutes) as specified in the MSDS/SOP for the disinfectant.
- Ventilate the isolator post-fumigation if required and ensure all vapors are neutralized.
5.4 Post-Sanitization Checks
- Visually inspect all internal areas of the isolator to ensure no chemical residues remain.
- Perform swab tests at predefined locations (Annexure-1) for microbial monitoring post-sanitization.
- Record results in the Isolator Sanitization Log (Annexure-2).
- Label the isolator with “SANITIZED” status tag along with date/time and initials of the operator and QA reviewer.
5.5 Frequency
- Routine sanitization: Before start of each aseptic operation batch.
- In case of product changeover, or observed contamination or as per validated frequency.
5.6 Safety Precautions
- Refer to the Safety Data Sheet (SDS) of the disinfectant before use.
- Ensure isolator chamber is sealed before fumigation or fogging starts.
- Never reuse disinfectant solutions beyond their validated hold time.
6. Abbreviations
- SOP: Standard Operating Procedure
- PPE: Personal Protective Equipment
- QA: Quality Assurance
- WFI: Water for Injection
- MSDS: Material Safety Data Sheet
- VHP: Vaporized Hydrogen Peroxide
7. Documents
- Annexure-1: Isolator Microbial Monitoring Locations
- Annexure-2: Isolator Sanitization Log
- Annexure-3: Disinfectant Usage Record
8. References
- EU GMP Annex 1: Manufacture of Sterile Medicinal Products
- USP <797>: Pharmaceutical Compounding — Sterile Preparations
- 21 CFR Part 211
9. SOP Version
Version: 2.0
10. Approval Section
|
Prepared By |
Checked By |
Approved By |
| Signature |
|
|
|
| Date |
|
|
|
| Name |
|
|
|
| Designation |
Manufacturing Executive |
QA Executive |
Head QA |
| Department |
Production |
Quality Assurance |
Quality Assurance |
11. Annexures
Annexure-1: Isolator Microbial Monitoring Locations
| Location |
Swab ID |
Result (cfu) |
Limit |
Status |
| Left Wall |
SWB-01 |
0 |
≤1 |
Pass |
| Glove Port 1 |
SWB-02 |
0 |
≤1 |
Pass |
Annexure-2: Isolator Sanitization Log
| Date |
Isolator ID |
Disinfectant Used |
Operator |
QA Reviewer |
| 23/06/2025 |
ISO-01 |
Hydrogen Peroxide |
Ravi Kumar |
Meena Gupta |
Annexure-3: Disinfectant Usage Record
| Batch No. |
Preparation Date |
Expiry |
Used For |
Prepared By |
| HP202506 |
22/06/2025 |
23/06/2025 |
ISO-01 |
Sunil Mehta |
Revision History:
| Revision Date |
Revision No. |
Details |
Reason |
Approved By |
| 01/01/2022 |
1.0 |
Initial version |
New SOP |
Head QA |
| 24/06/2025 |
2.0 |
Included VHP method and updated disinfection policy |
Annual Review |
Head QA |